Aerovate regains Nasdaq audit committee compliance by appointing Habib J. Dable

Jade Biosciences, Inc.

Company notified Nasdaq of noncompliance on Oct 11 due to only two audit committee members after Dr. Katabi's resignation.
Board appointed director Habib J. Dable to the audit committee effective Oct 17, 2024.
With Dable's appointment, Aerovate regained compliance with Nasdaq Listing Rule 5605(c)(2).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.